In the last trading session, 82939.0 Cytosorbents Corp (NASDAQ:CTSO) shares changed hands as the company’s beta touched 0.59. With the company’s per share price at $0.89 changed hands at $0.05 or 6.54% during last session, the market valuation stood at $48.97M. CTSO’s last price was a discount, traded about -104.49% off its 52-week high of $1.82. The share price had its 52-week low at $0.70, which suggests the last value was 21.35% up since then. When we look at Cytosorbents Corp’s average trading volume, we note the 10-day average is 0.2 million shares, with the 3-month average coming to 131.37K.
Cytosorbents Corp (NASDAQ:CTSO) trade information
Instantly CTSO was in green as seen at the end of in last trading. With action 10.26%, the performance over the past five days has been green. The company’s shares are showing year-to-date downside of -19.53%, with the 5-day performance at 10.26% in the green. However, in the 30-day time frame, Cytosorbents Corp (NASDAQ:CTSO) is -2.91% down. Looking at the short shares, we see there were 1.38 million shares sold at short interest cover period of 9.57 days.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Cytosorbents Corp (CTSO) estimates and forecasts
Data shows that the Cytosorbents Corp share is performing relatively much better than most of its peers within the same industry. As can be gleaned from the statistics, the company’s share value shot 14.51% over the past 6 months, a 53.13% in annual growth rate that is considerably higher than the industry average of 12.60%. Year-over-year growth is forecast to reach 5.99% up from the last financial year.
Consensus estimates given by 3 financial analysts project the company’s revenue in the current quarter to hit an average of 9.45M. 2 analysts are of the opinion that Cytosorbents Corp’s revenue for the current quarter will be 10.09M. The company’s revenue for the corresponding quarters a year ago was 8.67M and 9.79M respectively. According to analysts, the company will likely register a growth in its current quarter sales, forecast at 9.05%. The estimates for the next quarter sales put growth at 3.08%.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of -2.64%. The 2024 estimates are for Cytosorbents Corp earnings to increase by 53.12%.
CTSO Dividends
Cytosorbents Corp is expected to release its next quarterly earnings report in January.
Cytosorbents Corp (NASDAQ:CTSO)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 3.90% of Cytosorbents Corp shares while 33.29% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 34.64%. There are 33.29% institutions holding the Cytosorbents Corp stock share, with AVENIR CORP the top institutional holder. As of 2024-06-30, the company held 5.4738% of the shares, roughly 2.97 million CTSO shares worth $2.09 million.
SKYLANDS CAPITAL, LLC holds the second largest percentage of outstanding shares, with 5.2352% or 2.84 million shares worth $2.0 million as of 2024-06-30.
